If you have been reading about research peptide and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-04-22. Where a claim depends on a specific study, the study is described rather than over-claimed.
Proposed mechanisms include interaction with the nitric oxide system, modulation of growth factor signaling, and effects on blood vessel formation. None of these has been established as the primary mode of action, and some proposed pathways rest on indirect measurements. Whether the reported effects depend on a specific receptor has not been determined. Stability in gastric acid, unusual for a peptide of this size, is also reported in animal work, but the reason for it is not firmly established.
Published studies on BPC-157 are dominated by animal models. Commonly used endpoints include healing of surgically induced lesions in the stomach, tendon-to-bone attachment after transection, and recovery from experimentally induced vascular or intestinal damage. Many of these reports come from a small number of research groups, and the peptide is often described as acting across a wide range of tissue types. That breadth is itself a point of discussion, since one molecule influencing many unrelated systems is unusual.
Human data are far more limited than animal data. A small number of clinical reports exist, generally with few participants and without the randomization or blinding expected in later-phase trials. No large, independently replicated human trial has appeared in the indexed peer-reviewed literature. Statements about effects in people therefore rest on extrapolation from animal work rather than on direct evidence, and the strength of that extrapolation remains an open question rather than a settled matter.
Within the research literature, the peptide is discussed through several provisional mechanisms, including cytoprotection, modulation of growth factor signaling, and interaction with the nitric oxide system. None of these mechanisms is fully characterized, and no single pathway is universally accepted. Review articles typically note the gap between consistent animal findings and sparse human evidence. The compound is classified as a research chemical rather than an approved pharmaceutical, which shapes how studies are designed, funded, and reported.
BPC-157 is a synthetic pentadecapeptide with the sequence GEPPPGKPADDAGLV, corresponding to a partial fragment of a larger protein detected in human gastric juice. The name derives from the parent protein designation BPC, an abbreviation of body protection compound, with 157 acting as a fraction or batch identifier used by the original investigators. Its molecular weight is approximately 1419 daltons, and the chain contains no unusual residues or disulfide bridges. In the literature it is described as a short, water-soluble fragment rather than a complete natural protein.
| Property | Value | Notes |
|---|---|---|
| Study species | Rodents, mainly rats | Most reports use surgically induced injury models |
| Typical administration route | Subcutaneous or intraperitoneal injection | Routes differ between reports, which complicates comparison |
| Human trial evidence | Limited, small-scale reports | No large randomized trial in indexed journals |
| Reported outcome categories | Mucosal healing, tendon repair, vascular recovery | Endpoints are not standardized across studies |
| Mechanism status | Not established | Proposed pathways lack direct confirmation |
Early work on this family of molecules examined fractions of human gastric juice, where a larger protein was reported to protect gastrointestinal tissue in animal models. BPC 157 was designed as a shorter, more stable fragment of that protein and then studied on its own. The peptide itself is not a normal dietary component and is not present in the human body in meaningful quantities. Descriptions of its origin therefore refer to the research lineage of a laboratory molecule rather than to an endogenous or nutritional substance.
The sequence contains an unusually high proportion of proline and glycine, which limits regular secondary structure and contributes to solubility in aqueous media. The compound dissolves readily in water and in normal saline. Because it is a peptide, digestive enzymes are expected to break it down if it is swallowed, a consideration that influences the routes of administration used in animal experiments. Detailed conformational data remain limited, and published structural models are largely computational.
BPC 157 is a synthetic peptide built from fifteen amino acids. The letters stand for body protection compound, and the number is a laboratory code rather than a description of any biological feature. Its single-letter sequence is GEPPPGKPADDAGLV, which corresponds to a calculated mass near 1419.5 daltons. The material is produced by solid-phase peptide synthesis and is distributed as a lyophilized powder, not as a purified extract from a natural source.
Identity and purity are usually assessed with reversed-phase high-performance liquid chromatography, often paired with mass spectrometry using electrospray or MALDI ionisation. Amino acid analysis and peptide mapping by enzymatic digestion provide additional sequence-level confirmation. Purity is commonly reported as an area percentage from a chromatographic trace, and water content can be measured by Karl Fischer titration. Reported masses may differ by tens of daltons between sources because preparations can contain acetate or trifluoroacetate counterions, and such differences are not by themselves evidence of a different peptide.
BPC-157 is normally distributed as a lyophilised powder that ranges from white to off-white in appearance. The peptide dissolves readily in water, normal saline, and common aqueous buffers, and it is poorly soluble in nonpolar solvents such as hexane or vegetable oils. Lyophilised vials take up moisture if left open, which changes the mass of powder in the container and complicates any later weighing. Because the material is handled in small quantities, static and adhesion to glass or plastic can also cause noticeable losses during transfer.
60. Vopr Onkol. 2001;47(5):601-7. [Effect of vilon and epithalone on induction and growth of induced bladder neoplasms in rats]. [Article in Russian] Pliss GB(1), Mel'nikov AS, Malinin VV, Khavinson VKh. Author information: (1)N.N. Petrov Research Institute of Oncology, Ministry of Health of the RF, St. Petersburg. Experimental data on the effect of peptides--Vilon (Lys-Glu) and Epitalon (Ala-Glu-Asp-Gly)--on induction of urinary bladder tumors in rats are presented. Treatment with Vilon was followed by a significant fall in tumor incidence in 56% of experimental animals, as compared with 75.5% in control, as well as inhibition of early-onset neoplastic changes in the bladder mucosa. No inhibitory effect of Epitalon was recorded.
=== Audio === The Index includes "a pair of ultra near-field, full-range, off-ear (extra-aural) headphones", which use Balanced Mode Radiator (BMR) drivers to produce accurate and low-frequency sounds. The headset also has a built-in microphone.
== External links == "Rosiglitazone". MedlinePlus. U.S. National Library of Medicine. Peck P (20 July 2004). "Rosiglitazone May Improve Function in Patients With Mild Alzheimer's Disease". Medscape. "Rosiglitazone". Drug Information Portal. U.S. National Library of Medicine. Archived from the original on May 11, 2009.
Prime Minister of Kosovo Official Website (in English) PDK Partia Demokratike e Kosovës (in Albanian) Kryetari Thaçi: Populli i Kosovës dhe UÇK-ja ishin një A Thaçi interview by "Kosova Sot" daily (in Albanian) BBC News Profile Thaçi comments on the future of Kosovo at United States Institute of Peace War crimes cases: Case KSC-BC-2020-06: Hashim Thaçi et al. Case KSC-BC-2023-12: Hashim Thaçi et al. (administration of justice)
Species Calotropis acia Buch.-Ham. - India Calotropis gigantea (L.) Dryand. - China, Indian Subcontinent, Southeast Asia Calotropis procera (Aiton) Dryand. - China, Indian Subcontinent, Southeast Asia, Middle East, North Africa formerly included Calotropis sussuela, synonym of Hoya imperialis
Sources: pubmed.ncbi.nlm.nih.gov
As relations between Washington and Moscow improved, both governments increasingly worked to restrain their respective regional allies—pressuring their former proxies to make peace with one another—and establish negotiated settlements instead, while the US concomitantly stressed market globalization. In southern Africa, Soviet and Cuban support for the Angolan government diminished as diplomacy advanced, while the United States reduced backing for anti-communist insurgents, enabling peace processes that culminated in the late 1980s. Overall, this détente which accompanied the final twilight of the Cold War would help bring about a relatively more peaceful international environment. As a consequence of the Revolutions of 1989 and the adoption of a foreign policy based on non-interference by the Soviet Union, the Warsaw Pact rapidly lost its political and military rationale and began to dissolve. Meanwhile, troops stationed across eastern Europe began returning to the Soviet Union, completing their withdrawal by the mid-1990s. This marked the end of the Soviet military presence that had defined the political order in Europe since 1945. For all the complexity and geopolitical strain that the great power competition of the Cold War brought onto Europe during the second half of the 20th century, its trajectory turned out to be both "more prosperous and peaceful for Europeans than the first," so quips German historian Konrad Jarausch.
During his second presidency, Donald Trump launched a campaign of anti-LGBTQ+ and especially anti-transgender policies that eliminated federal recognition of transgender people, stripped legal protections, and sought to erase trans identities from public life. Through a series of executive orders, the administration defined sex strictly by birth biology, banned trans people from the military, restricted or defunded gender-affirming healthcare, censored research and education materials, and targeted schools, universities, and cultural institutions accused of promoting "gender ideology". Additional measures barred transgender athletes from sports, limited passport access, and fueled international efforts to undermine trans rights. Accompanied by rhetoric portraying transgender people as a societal threat, these policies triggered widespread legal challenges, condemnation from human rights groups, and a surge in emigration and asylum claims by transgender Americans.
=== Malaria vaccine === In 2014, GSK applied for regulatory approval for the first malaria vaccine. Malaria is responsible for over 650,000 deaths annually, mainly in Africa. Known as RTS,S, the vaccine was developed as a joint project with the PATH vaccines initiative and the Bill and Melinda Gates Foundation. The company has committed to making the vaccine available in developing countries for five per cent above the cost of production. As of 2013, RTS,S, which uses GSK's proprietary AS01 adjuvant, was being examined in a Phase 3 trial in eight African countries. PATH reported that "[i]n the 12-month period following vaccination, RTS,S conferred approximately 50% protection from clinical Plasmodium falciparum disease in children aged 5-17 months, and approximately 30% protection in children aged 6-12 weeks when administered in conjunction with Expanded Program for Immunization (EPI) vaccines." In 2014, Glaxo said it had spent more than US$350 million and expected to spend an additional US$260 million before seeking regulatory approval.
Bottromycin is a macrocyclic peptide with antibiotic activity. It was first discovered in 1957 as a natural product isolated from Streptomyces bottropensis. It has been shown to inhibit methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE) among other Gram-positive bacteria and mycoplasma. Bottromycin is structurally distinct from both vancomycin, a glycopeptide antibiotic, and methicillin, a beta-lactam antibiotic. Bottromycin binds to the A site of the ribosome and blocks the binding of aminoacyl-tRNA, therefore inhibiting bacterial protein synthesis. Although bottromycin exhibits antibacterial activity in vitro, it has not yet been developed as a clinical antibiotic, potentially due to its poor stability in blood plasma. To increase its stability in vivo, some bottromycin derivatives have been explored. The structure of bottromycin contains a macrocyclic amidine as well as a thiazole ring. The absolute stereochemistry at several chiral centers has been determined as of 2009. In 2012, a three-dimensional solution structure of bottromycin was published. The solution structure revealed that several methyl groups are on the same face of the structure. Bottromycin falls within the ribosomally synthesized and post-translationally modified peptide class of natural product.
Sources: en.wikipedia.org
Regorafenib (marketed under the trade name Stivarga) is currently being studied as a potential treatment option in multiple tumor types. On September 27, 2012, the FDA approved regorafenib for the treatment of patients with metastatic colorectal cancer who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-VEGF therapy, and, if KRAS wild-type, an anti-EGFR therapy. On February 25, 2013, the FDA approved regorafenib in a second indication to treat patients with locally advanced, unresectable or metastatic gastrointestinal stromal tumor (GIST) who have been previously treated with imatinib mesylate and sunitinib malate. Regorafenib is a compound developed by Bayer. The most common adverse reactions (≥ 20%) are asthenia/fatigue, hand-foot skin reaction (HFSR), diarrhea, decreased appetite/food intake, hypertension, mucositis, dysphonia and infection, pain (not otherwise specified), weight loss, abdominal pain, rash, fever and nausea. In 2011, Bayer entered into an agreement with Onyx under which Onyx will receive a 20 percent royalty on any future global net sales of regorafenib in oncology. Bayer and Onyx jointly promote Stivarga in the United States.
If the mixture produces bubbles or froth, the organism is said to be 'catalase-positive'. Staphylococci and Micrococci are catalase-positive. Other catalase-positive organisms include Listeria, Corynebacterium diphtheriae, Burkholderia cepacia, Nocardia, the family Enterobacteriaceae (Citrobacter, E. coli, Enterobacter, Klebsiella, Shigella, Yersinia, Proteus, Salmonella, Serratia), Pseudomonas, Mycobacterium tuberculosis, Aspergillus, Cryptococcus, and Rhodococcus equi. If not, the organism is 'catalase-negative'. Streptococcus and Enterococcus spp. are catalase-negative. While the catalase test alone cannot identify a particular organism, it can aid identification when combined with other tests such as antibiotic resistance. The presence of catalase in bacterial cells depends on both the growth condition and the medium used to grow the cells. Capillary tubes may also be used. A small sample of bacteria is collected on the end of the capillary tube, without blocking the tube, to avoid false negative results. The opposite end is then dipped into hydrogen peroxide, which is drawn into the tube through capillary action, and turned upside down, so that the bacterial sample points downwards. The hand holding the tube is then tapped on the bench, moving the hydrogen peroxide down until it touches the bacteria. If bubbles form on contact, this indicates a positive catalase result. This test can detect catalase-positive bacteria at concentrations above about 105 cells/mL, and is simple to use.
Members of both the Democratic & Republican parties who opposed Trump's border control policies regarded the border wall as unnecessary or undesirable, arguing that other measures would be more effective at reducing illegal immigration than building a wall, including tackling the economic issues that lead to immigration being a relevant issue altogether, border surveillance or an increase in the number of customs agents. Additionally, in August 2020, the United States constructed 3.8 km of short cable fencing along the border between Abbotsford, British Columbia, and Whatcom County, Washington. Border walls have formed a major component of European border control policy following the European migrant crisis. The walls at Melilla and at Ceuta on Spain's border with Morocco are designed to curtail refugees' and migrants' ability to enter the European Union via the two Spanish cities on the Moroccan coast. Similar measures have been taken on the Schengen area's borders with Turkey in response to the refugee crisis in Syria. The creation of the European Union's collective border security organisation, Frontex, is another aspect of the bloc's growing focus on border security. Within the Schengen Area, border security has become an especially prominent priority for the Hungarian government under right-wing strongman Viktor Orbán. Similarly, Saudi Arabia has begun construction of a border barrier or fence between its territory and Yemen to prevent the unauthorized movement of people and goods.
Although Fredrickson claims that her experimental results are still valid, these experimental results have also been questioned due to poor statistical methodology, and Alan Sokal has pointed out that "given [Fredrickson and Losada's] experimental design and method of data analysis, no data whatsoever could possibly give any evidence of any nonlinearity in the relationship between "flourishing" and the positivity ratio — much less evidence for a sharp discontinuity." Another study surveyed a U.S. sample of 3,032 adults, aged 25–74. Results showed 17.2 percent of adults were flourishing, while 56.6 percent were moderately mentally healthy. Some common characteristics of a flourishing adult included: educated, older, married and wealthy. The study findings suggest there is room for adults to improve as less than 20 percent of Americans are living a flourishing life. (Keyes, 2002). Benefits from living a flourishing life emerge from research on the effects of experiencing a high ratio of positive to negative affect. The studied benefits of positive affect are increased responsiveness, "broadened behavioral repertoires", increased instinct, and increased perception and imagination. In addition, the good feelings associated with flourishing result in improvements to immune system functioning, cardiovascular recovery, lessened effects of negative affect, and frontal brain asymmetry.
Bukele announced at the Bitcoin 2021 conference on 5 June 2021 that he would introduce a bill to the Legislative Assembly that would make bitcoin legal tender, saying that it would "generate jobs" and promote "financial inclusion" in the short term. The Legislative Assembly approved the bill three days later. Although the World Bank rejected a request from the Salvadoran government to assist it with the implementation of bitcoin as legal tender, citing concerns about transparency and the environmental effects of bitcoin mining, Athena Bitcoin announced that it would invest $1 million to install 1,500 bitcoin ATMs. This would allow users to exchange U.S. dollars for bitcoin and vice versa. Bitcoin became legal tender on 7 September 2021 in El Salvador, the first country to do so. It became legal tender alongside the United States dollar, which had been adopted in 2001 and replaced the Salvadoran colón. About 1,000 people marched in the streets of San Salvador to protest the country's adoption of bitcoin, though other citizens saw the adoption as an "opportunity." According to The New York Times, bitcoin adoption has allowed Salvadorans without bank accounts to "access digital payments, invest savings or boost earnings." The day before bitcoin became legal tender, Bukele announced that the Salvadoran government had bought its first 200 bitcoins. Economist Steve Hanke stated that El Salvador had "the most distressed sovereign debt in the world" due to its adoption of bitcoin, and other economists predicted that the country would likely default on its debt.
Sources: en.wikipedia.org
It is not authorized as a medicine in the United States or the European Union. Regulatory treatment varies by jurisdiction, and in several places it is handled as a research chemical. Therapeutic claims are not supported by large human trials.
Human evidence is sparse and comes from small reports rather than large trials. Sample sizes are generally too small to support firm conclusions. The published record does not contain an independently replicated randomized trial.
Several pathways have been proposed, including effects on nitric oxide signaling and vessel formation. Direct confirmation of a primary molecular target is lacking. Some findings rest on indirect measurements, which leaves the mechanism an open question.
The sequence corresponds to a fragment of a protein found in human gastric juice, so related sequences are natural. The isolated fifteen-amino-acid peptide supplied for research is produced synthetically. Whether the free fragment circulates naturally in humans has not been settled.